Commentary: Perioperative systemic therapy in early-stage non–small cell lung cancer: The future is bright

[摘要] In a flurry of recent clinical trials, immunotherapy and targeted therapies have been established as a promising new frontier for the treatment of early-stage non–small cell lung cancer (NSCLC). Indeed, the published literature is struggling to keep up with the tide of abstract presentations and press releases in this rapidly changing landscape. Several recent or soon-to-be published trials will significantly impact considerations for adjuvant and neoadjuvant systemic therapy.

[学科分类] 心脏病和心血管学